Quantitative PCR (RQ-PCR) in monitoring of minimal residual disease in Chronic Myeloid Leukemia patients
M Zawada - 2007 - portalwiedzy.cm-uj.krakow.pl
Philadelphia chromosome (Ph)-the characteristic chromosomal abnormality in
hematopoietic stem cells causes chronic myeloid leukemia (CML). It develops during …
hematopoietic stem cells causes chronic myeloid leukemia (CML). It develops during …
[PDF][PDF] Monitoring of Disease Activity in Chronic Myeloid Leukemia-chronic Phase Patients Treated with Indian Generic Veenat (NATCO) Imatinib Mesylate: A Tertiary …
K Dewan, T Chatterjee - Cancer Transl Med, 2015 - researchgate.net
Aim: Real‑time quantitative polymerase chain reaction (RT‑PCR) is a sensitive technique to
monitor treatment response in chronic myeloid leukemia (CML). Standardization of RT‑PCR …
monitor treatment response in chronic myeloid leukemia (CML). Standardization of RT‑PCR …
Assessment of the response to imatinib in chronic myeloid leukemia patients–comparison between the FISH, multiplex and RT‐PCR methods
P Raanani, I Ben‐Bassat, S Gan… - European journal of …, 2004 - Wiley Online Library
Objective: The objective of this study was to evaluate the kinetics of molecular response in
chronic myeloid leukemia (CML) patients treated with imatinib and to compare between the …
chronic myeloid leukemia (CML) patients treated with imatinib and to compare between the …
[HTML][HTML] Correlation of Molecular Response At 18 Month with Survival Benefits As Response-Related Prognostic Factor
Abstract Abstract 2766 Superior efficacy of Bcr-Abl tyrosine kinase inhibitors in chronic
myeloid leukemia (CML) therapy has increased the demand for more sensitive monitoring …
myeloid leukemia (CML) therapy has increased the demand for more sensitive monitoring …
Serial monitoring of BCR-ABL transcripts in chronic myelogenous leukemia (CML) treated with imatinib mesylate
M Hardling, Y Wei, L Palmqvist, B Swolin… - Medical oncology, 2004 - Springer
Survival among chronic myelogenous leukemia (CML) patients can be linked to the
reduction in leukemic cell burden. Treatment with imatinib mesylate results in a high …
reduction in leukemic cell burden. Treatment with imatinib mesylate results in a high …
Impact of second decline rate of BCR-ABL1 transcript on clinical outcome of chronic phase chronic myeloid leukemia patients on imatinib first-line
S Dulucq, G Etienne, S Morisset, E Klein, C Chollet… - Annals of …, 2019 - Springer
Early molecular response has been associated with clinical outcome in chronic myeloid
leukemia (CML) patients treated with tyrosine kinase inhibitors. The BCR-ABL1 transcript …
leukemia (CML) patients treated with tyrosine kinase inhibitors. The BCR-ABL1 transcript …
Praćenje odgovora bolesnika oboljelih od kronične mijeloične leukemije na liječenje inhibitorima tirozin-kinaze kvantitativnom lančanom reakcijom polimeraze u …
Sažetak Uvod: Kroz povijest je terapija kronične mijeloične leukemije (engl. chronic
myeloidleukemia, CML) imala puno revolucionarnih pomaka, među kojima je najvažniji …
myeloidleukemia, CML) imala puno revolucionarnih pomaka, među kojima je najvažniji …
[引用][C] haematologica 2004; 89: 49-57 [medline][PDF][index] Quantitative reverse transcription polymerase chain reaction should not replace conventional …
T Lange, T Bumm, S Otto, HK Al-Ali, I Kovacs, D Krug… - Haematologica, 2004
[HTML][HTML] Equivalence of BCR-ABL Transcript Levels< 1% According to the International Scale with Complete Cytogenetic Response in Chronic Phase CML Patients.
M Lauseker, B Hanfstein, C Haferlach, S Schnittger… - Blood, 2012 - Elsevier
Abstract Abstract 2495 Introduction: Response to therapy in patients with chronic myeloid
leukemia (CML) is monitored by both cytogenetic assessment of bone marrow metaphases …
leukemia (CML) is monitored by both cytogenetic assessment of bone marrow metaphases …
[PDF][PDF] The Role of Monitoring the Bcr-Abl Transcript Levels in the Management of Patients with Chronic Myeloid Leukemia
AB Tunyogi, I Benedek, JB Köpeczi, E Benedek… - Acta Marisiensis-Seria … - sciendo.com
Material and method: At the Clinical Hematology and BMT Unit Tîrgu Mureș, between 2008–
2011, we performed the molecular monitoring of bcr-abl transcript levels with RQ-PCR in 16 …
2011, we performed the molecular monitoring of bcr-abl transcript levels with RQ-PCR in 16 …